These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 9824049

  • 1. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N, Nakata K.
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [Abstract] [Full Text] [Related]

  • 2. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 3. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S.
    Cancer Res; 1995 Jul 15; 55(14):3105-9. PubMed ID: 7541712
    [Abstract] [Full Text] [Related]

  • 4. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
    Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K.
    Biochem Biophys Res Commun; 2001 Oct 05; 287(4):1034-40. PubMed ID: 11573968
    [Abstract] [Full Text] [Related]

  • 5. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
    Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K.
    Gene Ther; 1999 Apr 05; 6(4):465-70. PubMed ID: 10476206
    [Abstract] [Full Text] [Related]

  • 6. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M.
    Hepatology; 1996 Jun 05; 23(6):1359-68. PubMed ID: 8675152
    [Abstract] [Full Text] [Related]

  • 7. Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice.
    Ueki T, Nakata K, Mawatari F, Tsuruta S, Ido A, Ishikawa H, Nakao K, Kato Y, Ishii N, Eguchi K.
    Int J Mol Med; 1998 Apr 05; 1(4):671-5. PubMed ID: 9852281
    [Abstract] [Full Text] [Related]

  • 8. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
    Wills KN, Huang WM, Harris MP, Machemer T, Maneval DC, Gregory RJ.
    Cancer Gene Ther; 1995 Sep 05; 2(3):191-7. PubMed ID: 8528962
    [Abstract] [Full Text] [Related]

  • 9. Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
    Hsieh YJ, Liu RS, Hwu L, Ke CC, Wang FH, Wang HE, Chen FD.
    Anticancer Res; 2007 Sep 05; 27(3B):1571-9. PubMed ID: 17595778
    [Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
    Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WF, Chiang YL.
    Cancer Res; 1995 Nov 15; 55(22):5283-7. PubMed ID: 7585589
    [Abstract] [Full Text] [Related]

  • 11. Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene.
    Uto H, Ido A, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):550-5. PubMed ID: 10558907
    [Abstract] [Full Text] [Related]

  • 12. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y, Zhang X, Hui H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 19; 7(2):113-5. PubMed ID: 10488424
    [Abstract] [Full Text] [Related]

  • 13. Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy.
    Kawashita Y, Ohtsuru A, Miki F, Kuroda H, Morishita M, Kaneda Y, Hatsushiba K, Kanematsu T, Yamashita S.
    Gene Ther; 2005 Nov 19; 12(22):1633-9. PubMed ID: 16079887
    [Abstract] [Full Text] [Related]

  • 14. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R, Gérolami R, Bralet MP, Qian C, Tran PL, Tennant B, Prieto J, Bréchot C.
    Cancer Gene Ther; 2000 May 19; 7(5):657-62. PubMed ID: 10830712
    [Abstract] [Full Text] [Related]

  • 15. HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.
    Hirano T, Kaneko S, Kaneda Y, Saito I, Tamaoki T, Furuyama J, Tamaoki T, Kobayashi K, Ueki T, Fujimoto J.
    Gene Ther; 2001 Jan 19; 8(1):80-3. PubMed ID: 11402306
    [Abstract] [Full Text] [Related]

  • 16. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y, Kaneko S, Nakamoto Y, Kagaya T, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2001 Oct 19; 8(10):695-704. PubMed ID: 11687892
    [Abstract] [Full Text] [Related]

  • 17. Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
    Uch R, Gérolami R, Faivre J, Hardwigsen J, Mathieu S, Mannoni P, Bagnis C.
    Cancer Gene Ther; 2003 Sep 19; 10(9):689-95. PubMed ID: 12944988
    [Abstract] [Full Text] [Related]

  • 18. [Recombinant plasmid pEGFP-AFP-TK delivered by nano-magnetic fluids targeting killed AFP positive HepG2 cells in vitro].
    Luo Y, Zhang YD, Peng J, Yan HX, Xue D, Wu K, Zhou L, Hang SW, Zhao JF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May 19; 25(5):437-9. PubMed ID: 19426602
    [Abstract] [Full Text] [Related]

  • 19. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK, Yang DH, Tang SH, Huang W, Lu XH.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 10; 86(2):106-10. PubMed ID: 16620715
    [Abstract] [Full Text] [Related]

  • 20. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
    Gao Ding Cheng, An W, Dai J.
    Cell Res; 1999 Sep 10; 9(3):225-35. PubMed ID: 10520605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.